Volume 21, Number 7—July 2015
CME ACTIVITY - Research
Parechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013–2014
Table 2
Sample and result |
Specimens, no. (%) |
Patients, no. (%) |
Total | 420 (100) | 308 (100) |
CSF | ||
Total samples tested | 168 (40) | 161 (52) |
HPeV+ (mean Ct 31.6)† | 123 (73) | 116 (72) |
PCR+ for HPeV and EV | 1 (1) | 1 (1) |
Stool | ||
Total samples tested | 156 (37) | 147 (48) |
HPeV+ (mean Ct 27.2) | 114 (73) | 106 (72) |
PCR+ for HPeV and EV | 2 (1) | 2 (1) |
Other | ||
Total samples tested | 96 (23) | 8 (28) |
HPeV+ | 52 (54) | 45 (52) |
PCR+ for HPeV and EV | 1 (1) | 1 (1) |
Sequenced: HPeV3 | 41 (14) | 41 (21) |
*CSF, cerebrospinal fluid; Ct, cycle threshold; EV, enterovirus; HPeV, human parechovirus; VIDRL, Victorian Infectious Disease Reference Laboratory: +, positive.
†At VIDRL, PCRs are run for 45 cycles, so any Ct value greater than 45 is considered negative.
1Current affiliation: Independent consultant, Freshwater, New South Wales, Australia
Page created: June 15, 2015
Page updated: June 15, 2015
Page reviewed: June 15, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.